{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:19:19Z","timestamp":1773832759712,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T00:00:00Z","timestamp":1484524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1038\/bmt.2016.343","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T15:27:04Z","timestamp":1484580424000},"page":"733-738","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Long term renal survival in patients undergoing T-Cell depleted versus conventional hematopoietic stem cell transplants"],"prefix":"10.1038","volume":"52","author":[{"given":"I G","family":"Glezerman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Devlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Maloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E A","family":"Jaimes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S A","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A A","family":"Jakubowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,16]]},"reference":[{"key":"BFbmt2016343_CR1","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1056\/NEJMra1404711","volume":"374","author":"S Hingorani","year":"2016","unstructured":"Hingorani S . Renal complications of hematopoietic-cell transplantation. N Engl J Med 2016; 374: 2256\u20132267.","journal-title":"N Engl J Med"},{"key":"BFbmt2016343_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1056\/NEJM199907013410103","volume":"341","author":"G Socie","year":"1999","unstructured":"Socie G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999; 341: 14\u201321.","journal-title":"N Engl J Med"},{"key":"BFbmt2016343_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/sj.bmt.1705710","volume":"40","author":"C Ferry","year":"2007","unstructured":"Ferry C, Gemayel G, Rocha V, Labopin M, Esperou H, Robin M et al. Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies. Bone Marrow Transplant 2007; 40: 219\u2013224.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016343_CR4","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.bbmt.2008.03.008","volume":"14","author":"A Al-Hazzouri","year":"2008","unstructured":"Al-Hazzouri A, Cao Q, Burns LJ, Weisdorf DJ, Majhail NS . Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2008; 14: 658\u2013663.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016343_CR5","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.bbmt.2007.06.008","volume":"13","author":"S Kersting","year":"2007","unstructured":"Kersting S, Hene RJ, Koomans HA, Verdonck LF . Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2007; 13: 1169\u20131175.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016343_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbmt.2005.08.036","volume":"12","author":"J Delgado","year":"2006","unstructured":"Delgado J, Cooper N, Thomson K, Duarte R, Jarmulowicz M, Cassoni A et al. The importance of age, fludarabine, and total body irradiation in the incidence and severity of chronic renal failure after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2006; 12: 75\u201383.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016343_CR7","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.1996.14.2.579","volume":"14","author":"R Miralbell","year":"1996","unstructured":"Miralbell R, Bieri S, Mermillod B, Helg C, Sancho G, Pastoors B et al. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease. J Clin Oncol 1996; 14: 579\u2013585.","journal-title":"J Clin Oncol"},{"key":"BFbmt2016343_CR8","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.bbmt.2010.02.006","volume":"16","author":"IG Glezerman","year":"2010","unstructured":"Glezerman IG, Jhaveri KD, Watson TH, Edwards AM, Papadopoulos EB, Young JW et al. Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010; 16: 976\u2013984.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016343_CR9","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1053\/j.ajkd.2012.09.020","volume":"61","author":"N Singh","year":"2013","unstructured":"Singh N, McNeely J, Parikh S, Bhinder A, Rovin BH, Shidham G . Kidney complications of hematopoietic stem cell transplantation. Am J Kidney Dis 2013; 61: 809\u2013821.","journal-title":"Am J Kidney Dis"},{"key":"BFbmt2016343_CR10","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.bbmt.2011.01.005","volume":"17","author":"AA Jakubowski","year":"2011","unstructured":"Jakubowski AA, Small TN, Kernan NA, Castro-Malaspina H, Collins N, Koehne G et al. T cell-depleted unrelated donor stem cell transplantation provides favorable disease-free survival for adults with hematologic malignancies. Biol Blood Marrow Transplant 2011; 17: 1335\u20131342.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016343_CR11","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/bmt.2014.302","volume":"50","author":"GS Hobbs","year":"2015","unstructured":"Hobbs GS, Hamdi A, Hilden PD, Goldberg JD, Poon ML, Ledesma C et al. Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts. Bone Marrow Transplant 2015; 50: 493\u2013498.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016343_CR12","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.bbmt.2013.02.018","volume":"19","author":"UD Bayraktar","year":"2013","unstructured":"Bayraktar UD, de Lima M, Saliba RM, Maloy M, Castro-Malaspina HR, Chen J et al. Ex vivo T cell-depleted versus unmodified allografts in patients with acute myeloid leukemia in first complete remission. Biol Blood Marrow Transplant 2013; 19: 898\u2013903.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016343_CR13","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2215\/CJN.04800908","volume":"4","author":"M Naesens","year":"2009","unstructured":"Naesens M, Kuypers DR, Sarwal M . Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol 2009; 4: 481\u2013508.","journal-title":"Clin J Am Soc Nephrol"},{"key":"BFbmt2016343_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1600-6143.2005.01131.x","volume":"6","author":"AS Weiss","year":"2006","unstructured":"Weiss AS, Sandmaier BM, Storer B, Storb R, McSweeney PA, Parikh CR . Chronic kidney disease following non-myeloablative hematopoietic cell transplantation. Am J Transplant 2006; 6: 89\u201394.","journal-title":"Am J Transplant"},{"key":"BFbmt2016343_CR15","doi-asserted-by":"publisher","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","volume":"145","author":"AS Levey","year":"2006","unstructured":"Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145: 247\u2013254.","journal-title":"Ann Intern Med"},{"key":"BFbmt2016343_CR16","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/kisup.2012.64","volume":"3","author":"KDIGO Working Group","year":"2013","unstructured":"KDIGO Working Group. Chapter 1: Definition and Classification of CKD. In: Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3: 19\u201362.","journal-title":"Kidney Int Suppl"},{"key":"BFbmt2016343_CR17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/sj.ki.5000055","volume":"69","author":"CR Parikh","year":"2006","unstructured":"Parikh CR, Coca SG . Acute renal failure in hematopoietic cell transplantation. Kidney Int 2006; 69: 430\u2013435.","journal-title":"Kidney Int"},{"key":"BFbmt2016343_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/kisup.2011.32","volume":"2","author":"KDIGO Working Group","year":"2012","unstructured":"KDIGO Working Group. Section 2: AKI Definition. In: Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012; 2: 19\u201322.","journal-title":"Kidney Int Suppl"},{"key":"BFbmt2016343_CR19","doi-asserted-by":"publisher","first-page":"2991a","DOI":"10.1182\/blood-2007-01-070045","volume":"110","author":"F Boulad","year":"2007","unstructured":"Boulad F, Jakubowski A, Papadopoulos EB, Hsu KC, Perales MA, van den Brink M et al. Phase II trial of a chemotherapy-only regimen of busulfan, melphalan, fludarabine and R-ATG followed by allogeneic T-cell depleted hematopoietic stem cell transplants for the treatment of myeloid malignancies. Blood 2007; 110: 2991a.","journal-title":"Blood"},{"key":"BFbmt2016343_CR20","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.bbmt.2011.02.002","volume":"17","author":"SM Devine","year":"2011","unstructured":"Devine SM, Carter S, Soiffer RJ, Pasquini MC, Hari PN, Stein A et al. Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: results of the blood and marrow transplant clinical trials network protocol 0303. Biol Blood Marrow Transplant 2011; 17: 1343\u20131351.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016343_CR21","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1182\/blood-2007-06-093880","volume":"110","author":"AA Jakubowski","year":"2007","unstructured":"Jakubowski AA, Small TN, Young JW, Kernan NA, Castro-Malaspina H, Hsu KC et al. T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. Blood 2007; 110: 4552\u20134559.","journal-title":"Blood"},{"key":"BFbmt2016343_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/0032472031000141247","volume":"1","author":"NH Collins","year":"1999","unstructured":"Collins NH, Fernandez J, Bleau S, Smith K, Cordero D, Alpdogan O et al. Comparison of bone marrow and G-CSF mobilized peripheral blood progenitor cells from single normal donors before and after T cell depletion. Cytotherapy 1999; 1: 223.","journal-title":"Cytotherapy"},{"key":"BFbmt2016343_CR23","first-page":"171","volume-title":"Bone Marrow and Stem Cell Processing: Manual of Current Techniques","author":"NH Collins","year":"1992","unstructured":"Collins NH, Bleau SA, Kernan NA, O'Reilly RJ T-cell depletion of bone marrow by treatment with soybean agglutinin and sheep red blood cell rosetting. In: Areman E, Deeg HJ, Sacher RA(eds). Bone Marrow and Stem Cell Processing: Manual of Current Techniques. Davis: Philadelphia, PA, USA, 1992, pp171."},{"key":"BFbmt2016343_CR24","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1182\/blood-2010-04-280966","volume":"117","author":"JN Barker","year":"2011","unstructured":"Barker JN, Byam C, Scaradavou A . How I treat: the selection and acquisition of unrelated cord blood grafts. Blood 2011; 117: 2332\u20132339.","journal-title":"Blood"},{"key":"BFbmt2016343_CR25","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/ki.1988.83","volume":"33","author":"HD Humes","year":"1988","unstructured":"Humes HD . Aminoglycoside nephrotoxicity. Kidney Int 1988; 33: 900\u2013911.","journal-title":"Kidney Int"},{"key":"BFbmt2016343_CR26","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1128\/AAC.41.8.1846","volume":"41","author":"D Vittecoq","year":"1997","unstructured":"Vittecoq D, Dumitrescu L, Beaufils H, Deray G . Fanconi syndrome associated with cidofovir therapy. Antimicrob Agents Chemother 1997; 41: 1846.","journal-title":"Antimicrob Agents Chemother"},{"key":"BFbmt2016343_CR27","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000167987","volume":"9","author":"G Deray","year":"1989","unstructured":"Deray G, Martinez F, Katlama C, Levaltier B, Beaufils H, Danis M et al. Foscarnet nephrotoxicity: mechanism, incidence and prevention. Am J Nephrol 1989; 9: 316\u2013321.","journal-title":"Am J Nephrol"},{"key":"BFbmt2016343_CR28","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0002-9343(01)00928-7","volume":"111","author":"S Harbarth","year":"2001","unstructured":"Harbarth S, Pestotnik SL, Lloyd JF, Burke JP, Samore MH . The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy. Am J Med 2001; 111: 528\u2013534.","journal-title":"Am J Med"},{"key":"BFbmt2016343_CR29","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1182\/blood-2014-01-550566","volume":"124","author":"ML Sorror","year":"2014","unstructured":"Sorror ML, Martin PJ, Storb RF, Bhatia S, Maziarz RT, Pulsipher MA et al. Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality. Blood 2014; 124: 287\u2013295.","journal-title":"Blood"},{"key":"BFbmt2016343_CR30","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/ndt\/gfp529","volume":"25","author":"M Touzot","year":"2010","unstructured":"Touzot M, Elie C, van Massenhove J, Maillard N, Buzyn A, Fakhouri F . Long-term renal function after allogenic haematopoietic stem cell transplantation in adult patients: a single-centre study. Nephrol Dial Transplant 2010; 25: 624\u2013627.","journal-title":"Nephrol Dial Transplant"},{"key":"BFbmt2016343_CR31","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1681\/ASN.2004030203","volume":"16","author":"RN Foley","year":"2005","unstructured":"Foley RN, Murray AM, Li S, Herzog CA, McBean AM, Eggers PW et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol 2005; 16: 489\u2013495.","journal-title":"J Am Soc Nephrol"},{"key":"BFbmt2016343_CR32","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1111\/j.1600-6143.2008.02408.x","volume":"8","author":"MJ Ellis","year":"2008","unstructured":"Ellis MJ, Parikh CR, Inrig JK, Kanbay M, Patel UD . Chronic kidney disease after hematopoietic cell transplantation: a systematic review. Am J Transplant 2008; 8: 2378\u20132390.","journal-title":"Am J Transplant"},{"key":"BFbmt2016343_CR33","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/sj.bmt.1705643","volume":"39","author":"EP Cohen","year":"2007","unstructured":"Cohen EP, Drobyski WR, Moulder JE . Significant increase in end-stage renal disease after hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 39: 571\u2013572.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016343_CR34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.semnephrol.2010.09.009","volume":"30","author":"A Kogon","year":"2010","unstructured":"Kogon A, Hingorani S . Acute kidney injury in hematopoietic cell transplantation. Semin Nephrol 2010; 30: 615\u2013626.","journal-title":"Semin Nephrol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2016343.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016343","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bmt.2016.343","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016343.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:14:14Z","timestamp":1648062854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2016343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,16]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["BFbmt2016343"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2016.343","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,16]]},"assertion":[{"value":"29 July 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}